**INTRODUCTION:** Cranioplasty can be performed with autograft, allograft or a combination of both. The difference in outcomes based on the material utilized is a clinical question of utmost interest to the practicing craniofacial surgeon. This study examines a large cohort of adult cranioplasty surgery patients to evaluate such outcomes.

**METHODS:** The Healthcare Cost and Utilization Project (HCUP) State Inpatient Databases (SID) for California and Florida from 2006 to 2011 were used. Patients who had cranioplasty were identified via ICD-9 coding. Patients \< 18 years of age were excluded. Type of surgery, age, number of diagnoses and procedures were used to assess for differences in outcomes. Univariate and multivariate analyses were performed.

**RESULTS:** 6,533 patients were identified. There were no statistically significant differences (p \> 0.05) in mortality (3.7% vs 4.9%), implant removal (0.6% vs 0.4%), DVT (3.7% vs 2.7%), PE (1.1% vs 0.7%), and MI (0.6% vs 0.6%) between bone grafting versus implant. There were statistically (but not clinically) significant differences (P \< 0.05) in SSI (1.5% vs 0.8%), sepsis (3.2% vs 2.0%), bleeding (2.7% vs 1.1%) and stroke (4.8% vs 6.5%).

Analysis of the cohort by age (18--39; 40--65; 66+) showed statistically significant differences in mortality (2.1% vs 3.9% vs 7.8%), MI (0% vs 0.6% vs 1.0%) and stroke (3.7% vs 5.8% vs 8.6%).

Number of diagnoses (1--10 vs 11+) and procedures (1--5 vs 6+) showed significant differences in mortality, implant removal, SSI, sepsis, MI and stroke among others with worse outcomes as each variable increased.

**CONCLUSION:** Analysis of two statewide databases appears to show no clinically significant differences in outcomes for patients undergoing cranioplasty based on the utilization of autograft versus allograft. Significant differences in outcomes are seen based on age, number of diagnoses and procedures, which are likely surrogate markers of the patients' physiologic status and comorbidities.
